Furthermore, we postulate that letrozole blocks estrogen synthesis to decrease estrogen signaling and break the feed-forward loop between estrogen and IL6/LIF cytokine signaling in the ovarian cancer tumor microenvironment. This evidence concerns the gene LIF and ovarian cancer.